!
!
"#$%&'(!%()*+,(!-!Maladie'de'Parkinson'et'vision!
! .!
!
'Capsule'service'Mars'2015'
!
La'maladie'de'Parkinson'et'la'vision'''''
!
Par$la$Docteure$Diane$G.$Bergeron,$optométriste$
paru$sur$le$site$de$l’association$des$optométristes$du$Québec$;$aoqnet.qc.ca$
!
/*(,!'(!*+(+''+%%(0(12!3(!'#!$4$&'#2+415!3(!$'&%!(1!$'&%!3(!$#2+(12%!6&+!14&%!,41%&'2(12!%4&77)(12!3(!
$'&%+(&)%!$)48'90(%!3(!%#12:5!3412!&1!841!1408)(!%412!3(!2;$(!3:<:1:)#2+7=!"()2#+1(%!!$#2>4'4<+(%!
1?#77(,2(12!6&(!'(!%;%290(!*+%&('5!,400(!'#!3:<:1:)(%,(1,(!0#,&'#+)(5!#'4)%!6&(!!3?#&2)(%!$(&*(12!
24&,>()!'?(1%(08'(!3(%!%;%290(%=!
!
@#)0+!,(%!0#'#3+(%!6&(!14&%!)(1,412)41%!3(!$'&%!(1!$'&%!%4&*(125!+'!;!#!'#!0#'#3+(!3(!@#)A+1%41!6&+!
$(&2! #77(,2()! '?B+'! (2! '#! *+%+41=! "(22(! $#2>4'4<+(! ,>)41+6&(! (2! 3:<:1:)#2+*(! #77(,2(! '(! %;%290(!
1()*(&C! ,(12)#'! (2! $)4*46&(! 3(%! 2)4&8'(%! (%%(12+(''(0(12! 042(&)%! $#)! '(! 3:)9<'(0(12! 3(%!
1(&)41(%!34$#0+1()<:2+6&(%=!
!
D(%!,#&%(%!%412!0#'!,411&(%5!0#+%!41!$#)'(!3(!'#!0#'#3+(!6&#13!$'&%!3(%!3(&C!2+()%!3(%!1(&)41(%!!
3(!'#!%&8%2#1,(!14+)(!4&!3&!D4,&%!E+<()!%412!#22(+12%=!D#!0#'#3+(!,400(1,(!>#8+2&(''(0(12!(12)(!
'?F<(!3(!GH!(2!IH!#1%5!0#+%!$(&2!,400(1,()!8(#&,4&$!$'&%!J(&1(=!
!
D(%!%+<1(%!'(%!$'&%!,411&%!3(!'#!0#'#3+(!%412!'?>;$()241+(!0&%,&'#+)(!6&+!(12)#K1(!&1(!)+<+3+2:!3(%!
0&%,'(%5!'(!2)(08'(0(12!#&!)($4%5!$)+1,+$#'(0(12!3(%!(C2):0+2:%5!(2!'?#A+1:%+(!6&+!(%2!&1(!'(12(&)!!
3?+1+2+#2+41!4&!3?(C:,&2+41!3(%!04&*(0(12%=!
!
L#+%!4&2)(!,(%!%+<1(%5!$'&%+(&)%!$)48'90(%!4,&'#+)(%!4&!*+%&('%!%412!%4&%M3+#<14%2+6&:%!(2!0#'!4&!
$(&!2)#+2:%N!+'!$(&2!%?#<+)!3(!3+$'4$+(5!3(!,>#1<(0(12!3(!'#!*+%+41!3(%!,4&'(&)%5!3(!3+0+1&2+41!3(!'#!
%(1%+8+'+2:!#&C!,412)#%2(%5!3(!$)48'90(!3(!042+'+2:!4&!3(!%:,>()(%%(!4,&'#+)(=!
!
">(O! '(%! 3(&C! 2+()%! 3(%! $#2+(12%5! 41! )(0#)6&(! 3(%! #140#'+(%! 3(! ,'+<1(0(125! '#! 3+0+1&2+41! 3&!
):7'(C(!3(!,'+<1(0(12!,#&%#12!&1(!8#+%%(!3(!'#!):<&'#2+41!3&!7+'0!'#,);0#'=!D#!%(1%#2+41!3PB+'!%(,!
$(&2! #&%%+! Q2)(! ,#&%:(! $#)! &1(! 3:7+,+(1,(! 3(! '#! ,4&,>(! 0&6&(&%(5! &1(! %&)7#,(! '#,);0#'(! 3(!
0#&*#+%(!6&#'+2:!(12)#K1#12!&1!(08)4&+''(0(12!%4&*(12!*#)+#8'(!6&+!$(&2!,#&%()!3(%!3+77+,&'2:%!3(!
'(,2&)(=!
!
D#! 8':$>#)+2(! (%2! #&%%+! $):%(12(! ,>(O! &1! 841! 1408)(! 3(! $#2+(12%! #22(+12%! 3(! '#! 0#'#3+(! 3(!
@#)A+1%41N! &1(! 2(''(! +17'#00#2+41! 3(%! $#&$+9)(%! $)4*46&(! 3(! '#! 34&'(&)! (2! &1! '#)04+(0(12!
(C,(%%+7=! D#! $):%(1,(! 3(! %6&#0(%! (2! 3(! ,)4R2(%! (C$'+6&(! '#! %(1%#2+41! 3(! ,4)$%! :2)#1<()%=! "(!
$)48'90(! %(! ,412)S'(! 7#,+'(0(12! #*(,! &1(! 8411(! >;<+91(! 3(%! $#&$+9)(%! (2! '?&2+'+%#2+41! 3(!!
,40$)(%%(%!,>#&3(%!(2!3(!'&8)+7+#12%=!
!
T?#&2)(%!#77(,2+41%!$(&*(12!24&,>()!'(%!$#&$+9)(%5!,400(!'(!8':$>#)4%$#%0(!6&+!(%2!&1(!3;%241+(!
3&!0&%,'(!4)8+,&'#+)(!$)4*46&#12!&1(!,412)#,2+41!+1*4'412#+)(!(2!%4&*(12!34&'4&)(&%(!3&!0&%,'(=!
!
!
"#$%&'(!%()*+,(!-!Maladie'de'Parkinson'et'vision!
! U!
!
'Capsule'service'Mars'2015'
!
D(! 8':$>#)4%$#%0(! $(&2! Q2)(! 7#,+'(0(12! ,412)S':! $#)! 3(%! +1J(,2+41%! 3(! '#! 24C+1(! 842&'+6&(5! 0#+%!
,?(%2! &1! 2)#+2(0(12! V! ):$:2()! 24&%! '(%! W! 4&! X! 04+%N! %+! '?+1J(,2+41! 1?(%2! $#%! (77+,#,(5! (1! 3()1+()!
)(,4&)%!41!$(&2!,>+)&)<+,#'(0(12!(1'(*()!&1(!$#)2+(!3(!'?4)8+,&'#+)(!$4&)!%4&'#<()!'(%!%;0$2S0(%=!
!
"'+1+6&(0(125! 41! $(&2! #&%%+! 48%()*()! '?#$)#C+(! 3(! '?4&*()2&)(! 6&+! (%2! &1(! +1,#$#,+2:! 3&! 0&%,'(!
:':*#2(&)! 3(! '#! $#&$+9)(5! %4+2! &1(! 3+77+,&'2:! 3?#04),()! 4&! 3(! ):#'+%()! '(! 04&*(0(12!
+13:$(13#00(12!3(%!#22(+12(%!042)+,(%!(2!%(1%+2+*(%=!Y4&2(%!'(%!#140#'+(%!3(%!$#&$+9)(%!$(&*(12!
,#&%()!3(! '?+))+2#2+41!(2!&1(! %(1%#2+41!3?B+'! %(,5!'?&2+'+%#2+41!+12(1%+*(!3(%! '&8)+7+#12%! 4,&'#+)(%! (%2!
24&J4&)%!)(,400#13:(=!
!
@#)!%41! (77(2! %&)!
'P+11()*#2+41!
(2!'(%!
04&*(0(12%!
0&%,&'#+)(%5! '(!
@
#)
A+1
%41!$(&2! #&%%+! Q2)(!
(1!,#&%(!
3#1%!
$'&%+(&)
%
!
$)48'90(%!
3(!*+%+41!
8+14,&
'#+)(=!
D(%!
$)48'90(%!
3(!
,41
*
()
<(1,(!
$(&*(12! $)4*46&()!
&1(!
#%2>:14$+(5!
'#!
3+$'4$+(!
(2!
0Q0(!'?(08)
4&+''(
0(125!
,):#12!
&1(!
7#2+<&(!*+%&(''(!
+0$4)2#12(!(C$'+6&#12!
(12)(!
#&2)
(%!
'#!
3+77+,&'2:!
3(!
'(,2&)(=!
Z1!
2)
#+2(0(12!
4)2>4$2+6&(!
$(&2!#+3()!V!
#22:1&()!
'(%!
%;0$2S0(%!3&)#12!
'(%!
$)
(0+()
%!
%2#3(%!
3(!'#!
0#'#3+(!
4&!
(1,4)(! &1(!
,4))(,2+41! $)+%0#2+6&(!
$(&2!
<)
#13(
0(12!
#0:'+4)()!
,(!
$)
48'90(=!
!
D
?#0$'+2&3(
!
3?#,,40043#2+41!
$(&2!
:<#'(0(12!
Q2)(!
3+0+1&:(!(2!
#<<)#*()!
'(%!%+<1(%!
(2!
%;0$2S0(%!
3(!'#!
$)(%8;2+(5!
0#+%! V! ,#&%(!
3(%!
04&*(0(12%!+1,412)S':%!
(2!3(%!
$4
%+2+41%!
$#)74+%!*+,+(&%(%!3(!'#!2Q2(5!+'!7#&2! 7#+)(!
#22(12+41!
(1!
,4))+<(#12!'#!
*+%+41!3(!$)9%!
#*(,!
3(%!
'(12+''(%!
0
&'
2+74,#'(%=!
[4&*(125!&1(!'(12+''(!
%+0$'(!
*+%+41!
$()0(22)#!
&1!
#'+<1(0(12! $'&%!
7#,+'(!
3(%! ;(&C!%&)!'(%!
2F,>(%!
*+%&('
'(%!3(!$)9%=!D#!
'&1(22(!
3(!
'(,2&)(! (%2!
341,!
&1(!
4$2+41!
+12:)(%%#12(5!(2!
%+!
'?+1,4174)2! 8+14,&'#+)(!
(%2!
(1,4)
(!
2)4$!
>#13+,#$#125!
)+(1!
1?(0$Q,>(!
'?&2+'+%#2+41!
3?&1(!4,,'&%+41!
$4&)!
&1(!
'(,2&)(!$)4'41<:(!
$'&%!
#<):#
8'(=!
!
D(%!
,413+2+41%!3?:,'#+)#<(!
$(&*(12!
:<#'(0(12!(C#,()8()!
&1!
$)48'90(!
3(!
,4174)2!
*+%&('=!
Z1!841!
:,'#+)
#<(!
$()0(22)#! 3?#*4+)!
&1!
,412)#%2(!
4$2+
0&05!&1(!
8411(! $(),($2+41!3(%!
,4&'(&)
%
!(2!&1!
1+*(#&!
3(!
8)
+''#1,(!
,4174)2#8'(N!
'(%!,41%(+'%!3(!
8#%(!
3?>;<+91(!
*+%&(''(!412!!
+,+!
24&2(!'(&)!
+0$4)
2#1,(=
!
!
@4&)!,(%!
$#2+(12%!
#22(+12%! 3(!'#!
0
#'#
3+(!3(! @#)A+1%415!'#!
$()2(!
3(!
241&%!
(2!3(!
,412)S'(!
0&%,&'#+)(%!
$(&2!
)($):%(12()!
$'&%+(&)
%
!$(2+2%!3(&+'%!
V!
7#+)(! $#)!
)
#
$$4)
2
! V!
'(&)
%
!
#,2+*+2:%!
>#
8+2&(''(%=! \1!
4$2+0+%#12!
'(&)!
,417
4)
2!
*+%&('5! 14&%!
$4&*41%5!
(1!2#12!
6&?4$
240:2)+%2(%5!
$):%()*()!
6&('6&(%M&1(%!
3(!,(%!
#,2+*+2:%!
(2!
#0:'+4)()!'(&)!
6&#'+2:!
3(!*+(=!
[+!
'(%! 0#+1%!
2)
(08'(12!
2)4$! $4&)!2(1+)!'(!J4&)1#'5!41!$(&2!
'(!
'+)(! %&)!
'?:,)#1!3?4)3+1#2(&)!
6&+!'&+!
1(!
2)(08'(!
$#%5! 0#+%!$4&)!,(!7#+)(! +'!7#&2!6&(!'(!
$#2+(12!$4)2(!
'#!
0(+''(&)
(!
,4))(,2+41!
*+%&(''(!
$4%%+8'(!(2!,?(%2!
'V!
6&(!142)(!
+12()*(12+41!$)(13!24&2(!
%41!
+0$4)
2#1,(=!
!
1.
Biousse,
V.,
B.
C. Skibell,
R. L.
Watts, D. N. Loupe, C. Drews-Botsch, N. J.
Newman.
«
Ophthalmologic
features of
P
ar
kinson
s
disease
»,
Neur
ology
,
janvier
2004,
vol.
62,
no 2.
2. The
Wills
Eye
Manual
:
Office
and
emergency
room
diagnose
and
treatment
of Eye disease, 5e éd.,
J
.
P
.
Ehler
s
,
C.
P
.
Shah (dir.),
Philadelphie,
PA,
Lippincott,
2008.
!
!
"#$%&'(!%()*+,(!-!Maladie'de'Parkinson'et'vision!
! W!
!
'Capsule'service'Mars'2015'
!
3. Chartes,
L. «
Visual
complaints
seen with
neurodegenerative
diseases
/
Alzheimer diseease, Parkinson disease,
associate
with
eye
mo
v
ement
disor
der
s
»,
Ophthalmology
T
imes
,
août 200
!
!
[()*+,(!"4'&01-!Vision'and'Parkinson’s'Disease!! .!
!
!
'' March'2015'
!
!
1 / 4 100%
La catégorie de ce document est-elle correcte?
Merci pour votre participation!

Faire une suggestion

Avez-vous trouvé des erreurs dans linterface ou les textes ? Ou savez-vous comment améliorer linterface utilisateur de StudyLib ? Nhésitez pas à envoyer vos suggestions. Cest très important pour nous !